Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker
2014 ◽
Vol 9
(10)
◽
pp. 1568-1572
◽
Keyword(s):
2013 ◽
Vol 27
(3)
◽
pp. 220-226
◽
2010 ◽
Vol 15
(4)
◽
pp. 359-368
◽
Keyword(s):
2017 ◽
Vol 34
(1)
◽
pp. 168-170
2006 ◽
Vol 118
(2)
◽
pp. 518-520
◽
Keyword(s):
Keyword(s):
2021 ◽
Keyword(s):